Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
BACKGROUND: Macrolide antibiotics such as erythromycin and roxithromycin (RXM) have an anti-inflammatory effect that may account for their clinical benefit in the treatment of chronic airway inflammatory diseases. However, the precise mechanism of this anti-inflammatory effect is not well understood...
Main Authors: | Ken-Ichi Kanai, Kazuhito Asano, Tadashi Hisamitsu, Harumi Suzaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2004-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629350400008810 |
Similar Items
-
Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999-01-01) -
Roxithromycin as Anti-Inflammatory Drug Improves Clinical Outcomes in Adult Patients with Bronchiectasis: A Double- Blinded Randomized, Placebo-Controlled Pilot Clinical Trial
by: Siwasak Juthong, et al.
Published: (2019-07-01) -
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
by: Hajime Terao, et al.
Published: (2003-01-01) -
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
by: Toshikazu Shimane, et al.
Published: (2001-01-01) -
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
by: Kern Y. Chai, et al.
Published: (2018-05-01)